Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Intimation of the proceedings of 31st Annual General Meeting (AGM) and disclosure of voting results and Scrutinizer''s Report.18-09-2018
18-09-2018
Shareholder Meeting / Postal Ballot-Outcome of AGM
Intimation of the proceedings of 31st Annual General Meeting (AGM) and disclosure of voting results.18-09-2018
Fixes Book Closure For AGM
This is to inform that the Register of Members & Share Transfer Books of the Company will remain closed from September 10, 2018 to September 17, 2018 (both days inclusive) for the purpose of 31st Annual General Meeting (AGM) of the Company to be held on September 17, 2018.30-08-2018
Announcement Under Regulation 30 (LODR) - Update
We hereby inform you that the Board of Directors at their meeting held on 13.08.2018, has decided to promote 100% wholly owned subsidiary Company (since incorporated) for the business operations in US and North American Countries. the details of the proposed company are enclosed herewith.14-08-2018
Financial Results For The Quarter Ended 30/06/2018
With reference to the captioned subject, Please find the enclosed documents in terms of Regulation 33 of SEBI (LODR) Regulations, 2015: 1.Un-Audited Standalone and Consolidated Financial Results for the first quarter ended 30th June, 2018. 2.Limited Review Report on Standalone and Consolidated Financials for the first quarter ended 30th June, 2018. It is further intimated that meeting was commenced at 11:00 A.M. and ended at 2:30 P.M.13-08-2018
Board Meeting Intimation for To Consider The Un-Audited Financial Results For The First Quarter Ended 30Th June, 2018
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve Un-audited financial results for the first quarter ended 30th June, 2018 in compliance of Regulation 33 of the said regulations. As per code of conduct for prevention of Insider Trading, framed and adopted in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015....03-08-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brijgopal Inani29-07-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Kumar Inani29-07-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramakant Inani29-07-2018
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukant Bhutada29-07-2018